GeneCopoeia is the industry leader in expression-ready ORF cDNA clones, and we also carry reporter plasmid clones carrying gene promoters and 3' UTR microRNA (miRNA) binding site targets. OmicsLink™ SARS-CoV-2-related ORF cDNA plasmid clones can be constructed in any of our more than 250 ready-to-go vector types expressing both SARS-CoV-2 viral proteins as well as host proteins, which you can select using the drop-down menus below.
OmicsLink™ SARS-CoV-2-related ORF cDNA plasmid clones are part of GeneCopoeia's COVID-19 Coronavirus Research Tools products.
Note: SARS-CoV-2-related ORF cDNA plasmid clones are for research purposes only. They are not intended for diagnostic or treatment usage in humans.
We also have OmicsLink™ ORF cDNA plasmid clones for the related virus SARS-CoV-1, which caused the 2002-2004 SARS outbreak.
To order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral Spike proteins in one of our more than 250 non-viral and lentiviral vector types, select the product ID from the table below and contact inquiry@genecopoeia.com. D614G, U.K. B.1.1.7 D614G, South Africa B.1.351 D614G, Brazil P.1 At the time of product introduction, GeneCopoeia's R&D team used the GISAID database to determine the most frequently-occurring mutations in the Spike proteins from each variant to incorporate into our Spike-expressing ORF clones. These mutational profiles are indicated below. Note that each variant can have different sub-lineages, which could contain a slightly different repertoire of mutations from the variants that we have made available. If you would like SARS-CoV-2 Spike-expressing ORF clones with a different set of mutations than we have currently available. please contact inquiry@genecopoeia.com for a custom project. To order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral proteins in one of our more than 250 non-viral and lentiviral vector types, select the product ID from the table below and contact inquiry@genecopoeia.com. GU280_gp08 For more information or to request a quote, please contact inquiry@genecopoeia.com. You can purchase ORF cDNA clones expressing human host proteins that SARS-CoV-2 interacts with, including ACE2, which encodes the receptor for SARS-CoV-2 on respiratory epithelial cells, in more than 250 non-viral and lentiviral vector types. Either view all standard clones using the buttons below, or choose human clones in several popular vector types in the table. If you don't see what you need here, please contact inquiry@genecopoeia.com. For more information or to request a quote, please contact inquiry@genecopoeia.com. ** Next-day shipping is available for NextDay ORF clones in bacterial stock format. Lead times for NextDay ORF clones in purified plasmid is ~3-5 days. Orders for NextDay ORF clones must be received by 12PM EST Mon-Thurs in order to be processed and shipped the next day. You can purchase ORF cDNA clones expressing human host proteins that SARS-CoV-2 interacts with, including TMPRSS2, a serine protease required for S protein priming, in more than 250 non-viral and lentiviral vector types. Either view all standard clones using the buttons below, or choose human clones in several popular vector types in the table. If you don't see what you need here, please contact inquiry@genecopoeia.com. For more information or to request a quote, please contact inquiry@genecopoeia.com. ** Next-day shipping is available for NextDay ORF clones in bacterial stock format. Lead times for NextDay ORF clones in purified plasmid is ~3-5 days. Orders for NextDay ORF clones must be received by 12PM EST Mon-Thurs in order to be processed and shipped the next day. The cyclophilins are a family of proline isomerases that function to aid in protein folding. Cyclophilins bind to the immunosuppressive drug cyclosporin A (CsA) and help mediate CsA's pharmacological function. While there is no published evidence yet that cyclophilins are involved in the pathogenesis of SARS-CoV-2, several groups have shown that CsA can inhibit several viruses, including the virus that caused the 2002-2004 SARS pandemic, SARS-CoV, in a cyclophilin A (CypA)-dependent fashion (reviewed in Tanaka, Y., et al., 2013. Viruses 5, 1,250). Further, CypA interacts with SARS-CoV Non-structural protein 1 (Nsp1) as demonstrated in a yeast 2-hybrid screen (Pfefferle, E., et al.. 2011; PLOS Pathogens doi: doi:10.1371/journal.ppat.1002331). SARS-CoV is highly similar to SARS-CoV-2, and, in fact, both viruses use ACE2 as their cellular receptor. Therefore, it is reasonable to include CypA in investigations of a potential role for CypA in SARS-CoV-2 pathogenesis. GeneCopoeia provides non-viral and lentiviral ORF cDNA clones in 250+ vector types for CYPA in human, mouse, and rat. Humans have two known isoforms of cyclophilin A (PPIA). You can order human cyclophilin ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below Mouse M. musculus has only one known isoform of cyclophilin A (PPIA). You can order mouse cyclophilin A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below. Rat R. norvegicus has only one known isoform of cyclophilin A (PPIA). You can order rat cyclophilin A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below. For more information or to request a quote, please contact inquiry@genecopoeia.com. FK506 binding proteins (FKBP) are, like cyclophilins, proline isomerases that bind to another immunosuppressive drug, FK506 and mediate its pharmacology. While there is no published evidence yet that FKBPs are involved in the pathogenesis of SARS-CoV-2, several groups have demonstrated that FKBP1A is important for assembly of the virus that caused the 2002-2004 SARS pandemic, SARS-CoV (Pfefferle, S., et al., 2011; PLOS Pathogens doi: 10.1371/journal.ppat.1002331). SARS-CoV is highly similar to SARS-CoV-2, and, in fact, both viruses use ACE2 as their cellular receptor. Therefore, it is reasonable to include FKBP1A in investigations of a potential role for FKBP1A in SARS-CoV-2 pathogenesis. GeneCopoeia provides non-viral and lentiviral ORF cDNA clones in 250+ vector types for FKBP1A in human, mouse, and rat. Humans have two known isoforms of FKBP1A. You can order human FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below Mouse M. musculus has four known isoforms of FKBP1A. You can order mouse FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below. Rat R. norvegicus has only one known isoform of FKBP1A. You can order rat FKBP1A ORF clones in more than 250 non-viral and lentiviral vector types by clicking on the Product ID for each isoform in the table below. For more information or to request a quote, please contact inquiry@genecopoeia.com. A recent publication in Nature (Gordon, et al., 2020) described the results of an affinity purification-mass spectrometry (AP-MS) screen that identified 332 human proteins that physically interact with 26 SARS-CoV-2 viral proteins. While it is unlikely that all 332 interactions are physiologically relevant, Gordon, et al. demonstrated that 66 of these human host proteins are potential targets of known drugs used for other purposes, and that a subset of these drugs inhibit viral replication in vitro. You can order all the clones encoding these human interacting proteins, either individually or as a complete library, in any of our 250+ non-viral or lentiviral vector types. To order complete libraries, please visit our ORF cDNA library page. Order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral Spike proteins
To view the Spike mutations in each Spike variant, refer to the table "Spike variant mutational profiles" below.
Product ID
Protein accession
Symbol
Alias
Spike genotype
Description
NV219
YP_009724390.1
S
GU280_gp02
WT
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene (codon optimized)
NV236
YP_009724390.1
S
GU280_gp02
D614G
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G mutation (codon optimized)
NV237
YP_009724390.1
S
GU280_gp02
N439K
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with N439K mutation (codon optimized)
NV238
YP_009724390.1
S
GU280_gp02
D614G, N439K
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with N439K, D614G mutations (codon optimized)
NV239
YP_009724390.1
S
GU280_gp02
D614G, E501Y
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, E501Y mutations (codon optimized)
NV240
YP_009724390.1
S
GU280_gp02
D614G, P681H
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, P681H mutations (codon optimized)
NV241
YP_009724390.1
S
GU280_gp02
D614G, Hv69-90deletion
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, Hv69-90deletion mutations (codon optimized)
NV242
YP_009724390.1
S
GU280_gp02
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, U.K. B.1.1.7 mutations (codon optimized)
NV244
YP_009724390.1
S
GU280_gp02
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, South Africa B.1.351 mutations (codon optimized)
NV245
YP_009724390.1
S
GU280_gp02
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with D614G, Brazil P.1 mutations (codon optimized)
NV247
YP_009724390.1
S
GU280_gp02
California B.1.427/B.1.429
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with California B.1.427/B.1.429 mutations (codon optimized)
NV248
YP_009724390.1
S
GU280_gp02
India B.1.617
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene with India B.1.617 mutations (codon optimized)
NV220
YP_009724390.1
S1
GU280_gp02
WT
surface glycoprotein subunit 1 [Severe acute respiratory syndrome coronavirus 2], mature peptide (codon optimized)
NV221
YP_009724390.1
S2
GU280_gp02
WT
surface glycoprotein subunit 2 [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
NV222
YP_009724390.1
RBD
GU280_gp02
WT
Receptor binding domain [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
Spike variant mutational profiles
SARS-CoV-2 variant
Spike mutations
Wild type (product IDs NV219, NV220, NV221, NV222)
None
D614G (product ID NV236)
D614G
N439K (product ID NV237)
N439K
N439K & D614G (product ID NV238)
N439K, D614G
N439K & N501Y (product ID NV239)
N439K, N501Y
D614G & P681H (product ID NV240)
D614G, P681H
D614G & Hv69-90deletion (product ID NV241)
Δ69-70, D614G
B.1.1.7 (first identified in the U.K.; product ID NV242)
Δ69-70, Δ144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
B.1.351 (first identified in South Africa; product ID NV244)
L18F, D80A, D215G,Δ242-244, K417N, E484K, N501Y, D614G, A701V
P.1 (first identified in Brazil; product ID NV245)
L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F
Order OmicsLink™ ORF cDNA clones expressing SARS-CoV-2 viral proteins
Product ID
Protein accession
Symbol
Alias
Description
NV201 (please inquire)
YP_009724389.1
orf1ab
GU280_gp01
orf1ab polyprotein [Severe acute respiratory syndrome coronavirus 2}, full-length gene
NV202
YP_009725297.1
orf1ab
GU280_gp01
leader protein [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV203
YP_009725298.1
orf1ab
GU280_gp01
nsp2n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV204
YP_009725299.1
orf1ab
GU280_gp01
nsp3n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV205
YP_009725300.1
orf1ab
GU280_gp01
nsp4n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV206
YP_009725301.1
orf1ab
GU280_gp01
3C-like proteinase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV207
YP_009725302.1
orf1ab
GU280_gp01
nsp6n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV208
YP_009725303.1
orf1ab
GU280_gp01
nsp7n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV209
YP_009725304.1
orf1ab
GU280_gp01
nsp8n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV210
YP_009725305.1
orf1ab
GU280_gp01
nsp9n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV211
YP_009725306.1
orf1ab
GU280_gp01
nsp10n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV212
YP_009725307.1
orf1ab
GU280_gp01
RNA-dependent RNA polymerase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV213
YP_009725308.1
orf1ab
GU280_gp01
helicase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV214
YP_009725309.1
orf1ab
GU280_gp01
3′-to-5′ exonuclease [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV215
YP_009725310.1
orf1ab
GU280_gp01
endoRNAse [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV216
YP_009725311.1
orf1ab
GU280_gp01
2′-O-ribose methyltransferase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV217 (please inquire)
YP_009725295.1
orf1a
GU280_gp01
orf1a polyprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV218
YP_009725312.1
orf1a
GU280_gp01
produced by pp1a only [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV223
YP_009724391.1
ORF3a
GU280_gp03
ORF3a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV224
YP_009724392.1
E
GU280_gp04
envelope protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV225
YP_009724393.1
M
GU280_gp05
membrane glycoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV226
YP_009724394.1
ORF6
GU280_gp06
ORF6 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV227
YP_009724395.1
ORF7a
GU280_gp07
ORF7a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV228
YP_009725318.1
ORF7b
ORF7b [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV229
YP_009724396.1
ORF8
GU280_gp09
ORF8 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV230
YP_009724397.2
N
GU280_gp10
nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV231
YP_009725255.1
ORF10
GU280_gp11
ORF10 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
*Note: Mature peptides are produced as a result of proteolytic processing of larger precursor proteins. To enable expression of these proteins in cells, an ATG has been added to the 5' end of the ORF sequence.
View all ACE2 ORF cDNA clones for human, mouse, and rat
Order human ACE2 ORF cDNA clones in popular vector types
Clones in yellow shading are available for next-day shipping in bacterial stock format.**
View all TMPRSS2 ORF cDNA clones for human, mouse, and rat
Order human TMPRSS2 ORF cDNA clones in popular vector types
Clones in yellow shading are available for next-day shipping in bacterial stock format.**
View all human cyclophilin A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
F0323
NM_021130.4
PPIA
CYPA, CYPH, HEL-S-69p
Homo sapiens peptidylprolyl isomerase A (PPIA), transcript variant 1, mRNA.
T2782
NM_001300981.1
PPIA
CYPA, CYPH, HEL-S-69p
Homo sapiens peptidylprolyl isomerase A (PPIA), transcript variant 2, mRNA.
View all mouse M. musculus cyclophilin A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
Mm17577
NM_008907.1
Ppia
2700098C05, Cphn, CyP-18, CypA
Mus musculus peptidylprolyl isomerase A (Ppia), mRNA.
View all rat R. norvegicus cyclophilin A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
Rn24256
NM_017101.1
Ppia
CYCA, CyP-A
Rattus norvegicus peptidylprolyl isomerase A (Ppia), mRNA.
View all human FKBP1A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
R0062
NM_000801.4
FKBP1A
FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE
Homo sapiens FK506 binding protein 1A (FKBP1A), transcript variant 1, mRNA.
Z8544
NM_001199786.1
FKBP1A
FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE
Homo sapiens FK506 binding protein 1A (FKBP1A), transcript variant 3, mRNA.
View all mouse M. musculus FKBP1A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
Mm02519
NM_008019.2
Fkbp1a
12kDa, FKBP12, FKBP12-T1, FKBP12-T2, Fkbp, Fkbp1, mFKBP1, mFKBP12
Mus musculus FK506 binding protein 1a (Fkbp1a), mRNA.
Mm38146
NM_001302078.1
Fkbp1a
FKBP12, Fkbp, Fkbp1
Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 4, mRNA.
Mm38147
NM_001302079.1
Fkbp1a
FKBP12, Fkbp, Fkbp1
Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 5, mRNA.
Mm38985
NM_001355078.1
Fkbp1a
FKBP12, Fkbp, Fkbp1
Mus musculus FK506 binding protein 1a (Fkbp1a), transcript variant 8, mRNA.
View all rat R. norvegicus FKBP1A ORF cDNA clones
Product ID
Accession
Symbol
Alias
Description
Rn24112
NM_013102.3
Fkbp1a
FKBP12, Fkbp2
Rattus norvegicus FKBP prolyl isomerase 1A (Fkbp1a), mRNA.
Related products
Webinars
Title: Advanced Tools For COVID-19 Coronavirus Research From GeneCopoeia
Presented Wednesday, September 9, 2020
The COVID-19 global pandemic, caused by the SARS-CoV-2 coronavirus, highlights an urgent need for diagnostic reagents, antiviral therapeutics, and vaccine development. In this webinar, we will discuss GeneCopoeia's advanced solutions including testing kits, SARS-CoV-2 pseudotyped virus, and other tools needed for research into combating this deadly disease.
Watch recorded webinar / Download slides
Publications
View selected publications citing GeneCopoeia's COVID-19 coronavirus plasmid clones from the recent literature
- Fernandes, M.F., et al. (2022). Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene1 responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein. bioRxiv doi: 10.1101/2022.01.11.475901 [OMICSLINK™ SARS-CoV-2 ORF8, ORF10, and M ORF expression clones]
- Zhang, L., et al. (2022). Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein. Critical Care doi: 10.1186/s13054-022-04034-9 [OMICSLINK™ ACE2, SARS-CoV-2 Spike ORF expression clones]
- Minenkova, O., et al. (2022). Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy. Molecular Therapy doi: 10.1016/j.ymthe.2022.02.013 [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
- Ostrov, D.A., et al. (2022).Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens doi: 10.3390/pathogens10111514 [OMICSLINK™ ACE2 lentiviral ORF expression clone]
- Riccio, A., et al. (2022). Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Cellular and Molecular Life Sciences doi: 10.1007/s00018-022-04246-w [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
- He, C-L., et al. (2022). Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products in vitro. bioRxiv doi: 10.1101/2020.12.13.420406 [OMICSLINK™ ACE2, DPP4 ORF expression clones]
- Kasopefoluwa, Y., et al. (2022). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 10.1128/mBio.02492 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
- Hu, J., et al. (2022). Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera. Genes & Diseases doi: 10.1016/j.gendis.2021.11.007 [OMICSLINK™ ACE2 ORF expression clone]
- Capcha, J.M.C., et al. (2022). Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine doi: 10.3389/fcvm.2020.618651 [OMICSLINK™ ACE2, TMPRSS2, Furin lentiviral ORF expression clones]
- Oguntuyo, K.Y., et al. (2021). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 0.1128/mBio.02492-20 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
- Lempp, F.A., et al. (2021). Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature doi: 10.1038/s41586-021-03925-1 [OMICSLINK™ DC-SIGN (CD209), L-SIGN (CLEC4M), SIGLEC1, TMPRSS2 or ACE2 lentiviral ORF expression clone]
- Hu, J., et al. (2020). Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2. Genes & Diseases doi: 10.1016/j.gendis.2020.07.006 [OMICSLINK™ ACE2 ORF expression clone]
- Capcha, J.M.C., et al. (2020). Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine doi: 10.3389/fcvm.2020.618651 [OMICSLINK™ ACE2, TMPRSS2, Furin lentiviral ORF expression clones]